Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q2 2025 Earnings

30AprConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.46

-0.39

-0.31

-0.24

Details

Expected EPS

-0.418251

Actual EPS

-0.46

Surprise EPS

-0.04

Surprise Percent

+9.98%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.46 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.